EventsEventsPodcasts
Loader
Find Us
ADVERTISEMENT

Sanofi seeks to launch blood disorder drug this year - CNBC

Sanofi seeks to launch blood disorder drug this year - CNBC
Sanofi seeks to launch blood disorder drug this year - CNBC Copyright Thomson Reuters 2023
Copyright Thomson Reuters 2023
By Reuters
Published on Updated
Share this articleComments
Share this articleClose Button

- French drugmaker Sanofi SA plans to launch a drug for rare bleeding disorder hemophilia A this year, Chief Executive Officer Paul Hudson told CNBC in an interview on Thursday.

The U.S. Food and Drug Administration last year accepted the marketing application for the therapy, which is being developed in collaboration with Swedish drugmaker Sobi, and is expected to decide on an approval status by Feb. 28.

Hemophilia A is an inherited bleeding disorder in which the blood does not clot normally. About 400 babies are born with this condition every year, although the exact number of people affected is not known, according to government data.

Share this articleComments

You might also like